4.5 Article

Potential Use of Supercharging Agents for Improved Mass Spectrometric Analysis of Monoclonal Antibodies and Antibody-Drug Conjugates

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jasms.2c00008

Keywords

-

Funding

  1. Swedish Foundation for Strategic Research [JB ID14-0081, SBL SB16-0039]
  2. Swedish Research Council [2015-4870]
  3. Recipharm OT Chemistry AB
  4. Swedish Foundation for Strategic Research (SSF) [ID14-0081] Funding Source: Swedish Foundation for Strategic Research (SSF)

Ask authors/readers for more resources

The addition of supercharging reagents improves the charge state and spectral quality of trastuzumab and ADCs under denaturing conditions, without affecting the DAR values.
The addition of supercharging (SC) reagents in electrospray ionization coupled mass spectrometry (ESI-MS) has demonstrated several advantages for protein analysis such as reduced required mass range of the instrument, narrowed charge-state distribution, increased sensitivity, and adduct suppression. The potential use of SC reagents to improve analyses of larger and complex protein molecules such as monoclonal antibodies and antibody-drug conjugates (ADCs) has not been previously reported. In this study, the effect of seven SC reagents (meta- nitrobenzyl alcohol (ni-NBA), dimethyl sulfoxide (DMSO), ortho-nitroanisole (o-NA), propane sultone (PS), ethylene carbonate (EC), propylene carbonate (PC), and sulfolane) on ESI-MS acquired spectra of deglycosylated, intact, and reduced trastuzumab and a vcMMAE-trastuzumab ADC was investigated under denaturing conditions. The addition of any of the SC reagents resulted in a higher average charge state observed for all tested reagents for both trastuzumab and the ADC and a narrower charge-state envelope for o-NA and 1% sulfolane for trastuzumab. However, improved peak shapes or increased sensitivity was observed for several reagents, overall increasing the spectra quality. Finally, it was shown that SC reagents can be safely used for ADC analysis without impacting the obtained drug-to-antibody (DAR) values, as all DAR values were within 0.1 from the control sample.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available